Align Technology Looks 24% Undervalued After Earnings Selloff
ALGN dropped 12% post-earnings despite beating EPS. Analysts peg fair value near $209—here's the trade case.
Align Technology got punished hard after its latest earnings report, and the market might be overreacting. The stock shed 12% following the release and is down more than 9% over the past 30 days. But here's the thing — ALGN actually met revenue expectations and beat on earnings per share. The selloff was driven almost entirely by softer forward guidance, which spooked short-term holders into dumping shares.
That knee-jerk reaction may have created a real opportunity. At its current price around $158.64, the stock is trading at what some analysts call a 24% discount to its fair value of roughly $209.07. That's not a rounding error — that's a meaningful gap you don't ignore if you're playing the long game on dental tech.
Read more Principal Financial Group May Be 49% Undervalued After Beam Deal →
The bull case rests on two specific growth drivers. First, Invisalign is expected to expand into new clinical indications, meaning more types of cases that orthodontists and dentists can treat with the product. Second, general practitioners — not just specialists — are increasingly adopting the technology. That's a wider distribution funnel, which translates directly into revenue scale over time.
One-year returns are still in positive territory despite the recent turbulence, which tells you the longer-dated trend hasn't broken. If you believe the guidance miss was conservative or temporary, the current price looks like a discount entry point rather than a warning sign. Volatility created the window — now it's a question of whether you trust the thesis.
Continue reading at Yahoo Finance
